

HY-172900 · 50 mg
MedChemExpress · Cat: HY-172900
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/akt-in-27.htmlDescription
AKT-IN-27 4a is a potential anticancer agent through selective therapeutic targeting of Akt-driven pathways. AKT-IN-27 4a induces apoptosis via caspase-3 activation, G2/M cell cycle arrest, and mitochondrial membrane potential disruption. AKT-IN-27 4a can be used in the research for TNBC triple-negative breast cancer .







